IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Tomasoni, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.755
AS - Asia 3.720
EU - Europa 1.842
SA - Sud America 942
AF - Africa 114
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.632
SG - Singapore 1.417
CN - Cina 902
BR - Brasile 791
HK - Hong Kong 546
IT - Italia 472
DE - Germania 320
VN - Vietnam 309
FR - Francia 175
FI - Finlandia 167
RU - Federazione Russa 164
GB - Regno Unito 156
TR - Turchia 137
IN - India 102
IE - Irlanda 71
BD - Bangladesh 69
AR - Argentina 64
UA - Ucraina 63
CA - Canada 54
MX - Messico 42
IQ - Iraq 40
NL - Olanda 38
JP - Giappone 37
ZA - Sudafrica 37
CZ - Repubblica Ceca 35
PL - Polonia 35
SA - Arabia Saudita 31
SE - Svezia 29
AT - Austria 27
PK - Pakistan 27
ES - Italia 24
EC - Ecuador 20
SC - Seychelles 20
CO - Colombia 16
MA - Marocco 16
VE - Venezuela 16
ID - Indonesia 15
KE - Kenya 13
EG - Egitto 11
PE - Perù 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
LT - Lituania 9
PH - Filippine 9
TN - Tunisia 9
BE - Belgio 8
JO - Giordania 8
BG - Bulgaria 7
NP - Nepal 7
PY - Paraguay 7
CL - Cile 6
LV - Lettonia 6
UY - Uruguay 6
CH - Svizzera 5
MD - Moldavia 5
PA - Panama 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
JM - Giamaica 4
MY - Malesia 4
PS - Palestinian Territory 4
BO - Bolivia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
RS - Serbia 3
AU - Australia 2
DZ - Algeria 2
GY - Guiana 2
IL - Israele 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MK - Macedonia 2
OM - Oman 2
RO - Romania 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
FJ - Figi 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
Totale 10.366
Salva come PNG Salva come JPEG
Città #
Singapore 721
Hong Kong 544
Ashburn 468
San Jose 388
The Dalles 259
Beijing 254
New York 197
Los Angeles 163
Chandler 138
Lauterbourg 134
Helsinki 120
Istanbul 113
Ho Chi Minh City 111
Dallas 107
Munich 106
Fairfield 103
Milan 80
São Paulo 76
Princeton 75
Dublin 71
Frankfurt am Main 68
Redondo Beach 61
Buffalo 60
Moscow 60
Hanoi 57
Romola 55
Chicago 53
Houston 48
Shanghai 46
Council Bluffs 44
San Francisco 44
Orem 42
Woodbridge 40
Wilmington 35
Seattle 34
Cambridge 32
Tokyo 32
London 30
Santa Clara 30
Brescia 28
Chennai 28
Jacksonville 28
Montreal 28
Brooklyn 27
Brno 26
Warsaw 25
Atlanta 24
Boston 24
Turku 24
Guangzhou 23
Ann Arbor 22
Haiphong 21
Nuremberg 19
Poplar 19
Rome 19
Johannesburg 18
Lappeenranta 18
Belo Horizonte 17
Stockholm 17
Washington 17
Brasília 16
Denver 16
Düsseldorf 16
Amsterdam 15
City of London 14
Phoenix 14
Porto Alegre 14
Rio de Janeiro 14
Dhaka 13
Hangzhou 13
Mumbai 13
Toronto 13
Baghdad 12
Da Nang 12
Kilburn 12
Turin 12
Vienna 12
Biên Hòa 11
Buenos Aires 11
Curitiba 11
Erbil 11
Manchester 11
Salt Lake City 11
Salvador 11
Charlotte 10
Nairobi 10
Querétaro 10
Riyadh 10
Trieste 10
Ankara 9
Campinas 9
Kyiv 9
Mexico City 9
Newark 9
Brussels 8
Cape Town 8
Changsha 8
Des Moines 8
Guayaquil 8
Jeddah 8
Totale 6.022
Salva come PNG Salva come JPEG
Nome #
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 181
August 2020 at a glance: focus on neurohormonal antagonists and electrolytes 153
2024 update in heart failure 151
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study 135
Acute heart failure: More questions than answers 131
Clinical characteristics and outcome of acute heart failure patients with mid-range ejection fraction. 126
In-hospital and long-term mortality for acute heart failure: analysis at the time of admission to the emergency department 126
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 118
The prognostic value of serial troponin measurements in patients admitted for COVID-19 115
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 112
Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure 111
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 109
Highlights in heart failure 108
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 106
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 106
Review: Evidence-Based Management of Acute Heart Failure 105
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC 102
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 101
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 101
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 99
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 97
Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score 97
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 94
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 92
[Sodium-glucose cotransporter 2 inhibitors and heart failure with preserved ejection fraction: the EMPEROR-Preserved and DELIVER studies] 92
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 92
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 90
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 90
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 90
The Mayo ATTR-CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis 89
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 89
2023 focused update of the 2021 ESC heart failure guidelines: Key messages for clinical practice 88
Prognostic significance of serum potassium in patients hospitalized for acute heart failure 87
April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction 87
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration 87
[Transcatheter devices for chronic heart failure: state of the art] 87
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 87
[Empagliflozin and heart failure: the EMPEROR-Reduced trial] 86
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 86
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 85
August 2021 at a glance: focus on cardiomyopathies, medical treatment and devices 85
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 85
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 84
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae 84
July 2020 at a glance: focus on imaging and cardiomyopathies 84
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 83
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 83
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 83
A year in heart failure: an update of recent findings 82
Heart failure: an update from the last years and a look at the near future 80
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 80
Updates in heart failure: sodium glucose co-transporter 2 inhibitors and beyond - major changes are coming 79
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines 78
September 2020 at a glance: focus on heart failure with preserved ejection fraction and medical therapy 78
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC 78
Impact of malnutrition in patients with severe heart failure 77
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry 76
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 76
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction 74
Direct Oral Anticoagulants for the Treatment of Left Ventricular Thrombus-A New Indication? A Meta-summary of Case Reports. 74
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 73
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 73
Impact and predictors of device-related thrombus after percutaneous left atrial appendage closure 73
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 72
Coronavirus disease 2019 and cardiovascular disease: what we have learnt during the last 2 years 72
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk 72
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 70
Heart failure in the last year: progress and perspective 70
August 2022 at a glance: focus on heart failure with preserved ejection fraction and cardiac amyloidosis 69
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial 68
Impact of Pulmonary Hypertension on Outcomes after Transcatheter Tricuspid Valve Edge-to-Edge Repair 67
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 67
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 67
Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis 67
April 2023 at a glance: focus on diagnosis and comorbidities 66
Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation 66
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 66
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration 64
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 64
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 63
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial 62
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 62
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 62
Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction 61
Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction 61
Management of hypertrophic cardiomyopathy 60
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 60
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial 60
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 59
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis 59
July 2021 at a glance: focus on blood volume distribution, haemodynamics and adherence to therapy 59
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 58
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction 58
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 58
Addressing comorbidities in heart failure: When feeling better and living longer go in the same direction 57
January 2023 at a glance: focus on acute heart failure and medical therapy 57
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy 57
Coronary artery disease: novel insights in a long-standing disease 56
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry 56
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis 56
Totale 8.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 21 15
2021/2022202 4 41 4 6 8 6 8 10 14 10 18 73
2022/2023486 59 36 8 18 36 137 7 32 73 15 31 34
2023/20241.152 59 13 106 90 74 136 82 23 278 38 43 210
2024/20252.595 21 28 95 247 247 229 283 124 212 271 486 352
2025/20265.685 567 767 480 871 502 377 727 306 408 495 185 0
Totale 10.497